Predict your next investment

HEALTHCARE | Drug Discovery
visterrainc.com

See what CB Insights has to offer

Business Relationships

7

Service Providers

5

Visterra Service Providers

5 Service Providers

Visterra has 5 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Investment Bank

Bookrunner

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Subscribe to see more

Associated Rounds

Provider Type

Investment Bank

Subscribe to see more

Subscribe to see more

Service Type

Bookrunner

Subscribe to see more

Subscribe to see more

Partnership data by VentureSource

Visterra Partners & Customers

7 Partners and customers

Visterra has 7 strategic partners and customers. Visterra recently partnered with Vir Biotechnology on October 10, 2017.

Date

Type

Business Partner

Country

News Snippet

Sources

10/18/2017

Licensee

Vir Biotechnology

United States

Visterra Announces Research Collaboration Exclusive License and Option Agreement for Infectious Diseases with Vir Biotechnology

We are very pleased that Vir Biotechnology , Inc. has chosen to partner with Visterra , Inc. and this collaboration will accelerate the advancement of our promising research programs focused on treating and preventing infectious diseases , '' said Brian J.G. Pereira , M.D .

9

3/30/2017

Client

CARB-X

United States

Subscribe to see more

Subscribe to see more

10

3/30/2017

Client

CARB-X

United States

Subscribe to see more

Subscribe to see more

10

3/30/2017

Partner

CARB-X

United States

Subscribe to see more

Subscribe to see more

10

10/5/2015

Client

Biomedical Advanced Research and Development Authority

United States

Subscribe to see more

Subscribe to see more

10

Date

10/18/2017

3/30/2017

3/30/2017

3/30/2017

10/5/2015

Type

Licensee

Client

Client

Partner

Client

Business Partner

Vir Biotechnology

CARB-X

CARB-X

CARB-X

Biomedical Advanced Research and Development Authority

Country

United States

United States

United States

United States

United States

News Snippet

Visterra Announces Research Collaboration Exclusive License and Option Agreement for Infectious Diseases with Vir Biotechnology

We are very pleased that Vir Biotechnology , Inc. has chosen to partner with Visterra , Inc. and this collaboration will accelerate the advancement of our promising research programs focused on treating and preventing infectious diseases , '' said Brian J.G. Pereira , M.D .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

9

10

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.